Partner Dan Shores will be a speaker at the 5th Annual mRNA-Based Therapeutics Summit taking place July 21-23, 2025, in Boston, Massachusetts. Dan's session, "Advanced Patent Considerations for mRNA Market Players and New Entrants," will take place on July 23 and will highlight key patent issues relating to mRNA therapeutics; review the latest mRNA IP and innovation trends; and offer strategies for operating in the complex mRNA/delivery space.
With 450+active mRNA drugs populating each phase of development and the industry rapidly expanding into new disease indications, this year’s 5th mRNA-Based Therapeutics Summit returns with a refreshed, comprehensive program spotlighting key progress and new data sharing from the community. As the world's largest, end-to-end mRNA conference, gathering 350+ global stakeholders, the biggest and newest players in the mRNA, Circular RNA & Self-Amplifying RNA fields including Moderna, Pfizer, BioNTech, Grann Pharmaceuticals, Celestial Therapeutics, Byterna Therapeutics and more will share exclusive scientific and strategic insights. This is the ultimate forum to take advantage of key networking opportunities, strategize your mRNA’s therapeutic potential, and successfully bring mRNA vaccines, therapeutics, and new technologies towards clinical and commercial success for patients in need.
To learn more and to register, please visit the event website.
